Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
fluad pediatric
- Development stage
- Approved
- Lead developer
- Novartis
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
FLUAD Pediatric is an inactivated trivalent influenza vaccine adjuvanted with MF59C.1 (an oil-in-water emulsion containing squalene). It contains purified hemagglutinin (HA) and neuraminidase (NA) surface antigens from three influenza virus strains (types A and B), as recommended annually by the World Health Organization and national immunization authorities. The vaccine is indicated for active immunization against influenza in children 6 months to less than 2 years of age. The MF59 adjuvant enhances the immune response to the viral antigens. Like other inactivated influenza vaccines, it works by stimulating antibody production against the included viral strains[2][7][9].
- Brand names
- FLUAD PediatricFLUAD
- Other names
- Influenza Virus Vaccine, Surface Antigen, Inactivated, Adjuvanted with MF59C.1aTIVChiromasGripguardInflupozzi Adiuvato
02
Targets
HA (Hemagglutinin)Neuraminidase
Beyond the preview
Go deeper on fluad pediatric.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on fluad pediatric.